Category: Mergers & Acquisitions
Invacare sells its Altimate Medical subsidiary, maker of standing-assistance devices, to Rockwood Equity Partners for about $23 million in cash.
Invacare (NYSE:IVC) is hoping to narrow its focus and reduce its debt after divesting its Altimate Medical subsidiary for $23 million in cash.
Boston Scientific says it's closed the $415 million acquisition of Bayer AG's interventions unit, nearly doubling the size of its peripherals business.
Boston Scientific (NYSE:BSX) said today that it closed on the $415 million cash buyout of Bayer AG's interventional unit it announced last May.
Johnson & Johnson puts its Cordis vascular device business on the auction block after years of sluggish growth.
Healthcare giant Johnson & Johnson (NYSE:JNJ) is looking to divest its Cordis business after years of lackluster sales for the company's stents, catheters and other vascular devices, according to a report from the Wall Street Journal.
Medtronic reveals that the tax tab for its top executives from its Covidien buyout will near $58 million, apart from the capital gains taxes all shareholders will pay on the $43 billion deal.
Covidien acquires Sapheon and its minimally invasive VenaSeal device for treating varicose veins for an undisclosed amount.
Botox-maker Allergan acquiesces to Valeant Pharmaceuticals' demands for a special shareholder meeting, but takes to court to prevent Valeant and its compatriots from voting their shares.
Yet another shareholder sues Covidien and its leaders, accusing them of short-changing investors in the $43 billion acquisition by Medtronic.